Order Article Reprints

Rivera D, Paudice M, Accorsi G, Valentino F, Ingaliso M, Pianezzi A, Roggieri P, Trevisan L, Buzzatti G, Mammoliti S, et al. The Advantages of Next-Generation Sequencing Molecular Classification in Endometrial Cancer Diagnosis. Journal of Clinical Medicine. 2023; 12(23):7236. https://doi.org/10.3390/jcm12237236

Rivera, Daniela, Michele Paudice, Giulia Accorsi, Floriana Valentino, Marta Ingaliso, Ada Pianezzi, Paola Roggieri, Lucia Trevisan, Giulia Buzzatti, Serafina Mammoliti, and et al. 2023. "The Advantages of Next-Generation Sequencing Molecular Classification in Endometrial Cancer Diagnosis" Journal of Clinical Medicine 12, no. 23: 7236. https://doi.org/10.3390/jcm12237236

Rivera, D., Paudice, M., Accorsi, G., Valentino, F., Ingaliso, M., Pianezzi, A., Roggieri, P., Trevisan, L., Buzzatti, G., Mammoliti, S., Barra, F., Ferrero, S., Cirmena, G., Gismondi, V., & Vellone, V. G. (2023). The Advantages of Next-Generation Sequencing Molecular Classification in Endometrial Cancer Diagnosis. Journal of Clinical Medicine, 12(23), 7236. https://doi.org/10.3390/jcm12237236